Tianyu Co., Ltd. announced on December 22 that its wholly-owned subsidiary Nuode Pharmaceutical recently received a drug registration certificate for trazodone hydrochloride tablets approved and issued by the State Drug Administration. Trazodone hydrochloride tablets are suitable for the treatment of depression and are effective for patients with or without anxiety.

Tianyu Co., Ltd. announced on December 22 that its wholly-owned subsidiary Nuode Pharmaceutical recently received a drug registration certificate for trazodone hydrochloride tablets approved and issued by the State Drug Administration. Trazodone hydrochloride tablets are suitable for the treatment of depression and are effective for patients with or without anxiety.